The present invention relates to spiroheterocycl-dihydropyrimidines, their use as modulators of γ-secretase and to pharmaceutical compositions containing said compounds. In particular, the present invention relates to compounds which interfere with γ-secretase and/or its substrate and therefore modulate the formation of Aβ peptides.
[EN] DIHYDROPTERIDINONES II<br/>[FR] DIHYDROPTÉRIDINONES II
申请人:BOEHRINGER INGELHEIM INT
公开号:WO2014127816A1
公开(公告)日:2014-08-28
The present invention relates to spiroheterocycl-dihydropyhmidines, their use as modulators of γ-secretase and to pharmaceutical compositions containing said compounds. In particular, the present invention relates to compounds which interfere with γ-secretase and/or its substrate and therefore modulate the formation of Αβ peptides.
The present invention relates to dihydropteridinones, their use as modulators of γ-secretase and to pharmaceutical compositions containing said compounds. In particular, the present invention relates to compounds which interfere with γ-secretase and/or its substrate and therefore modulate the formation of Aβ peptides.
[EN] DIHYDROPTERIDINONES I<br/>[FR] DIHYDROPTÉRIDINONES I
申请人:BOEHRINGER INGELHEIM INT
公开号:WO2014127815A1
公开(公告)日:2014-08-28
The present invention relates to dihydropteridinones, their use as modulators of γ-secretase and to pharmaceutical compositions containing said compounds. In particular, the present invention relates to compounds which interfere with γ-secretase and/or its substrate and therefore modulate the formation of Αβ peptides.